BUSINESS BRIEFING / BIOTECHNOLOGY
- Share via
Times Wire Reports
Biogen Idec Inc. shareholders elected two of billionaire investor Carl Icahn’s nominees and two company-backed directors to its board after a proxy contest.
Preliminary results show shareholders elected Robert W. Pangia, William D. Young, Alex Denner and Richard Mulligan to the board, Biogen reported.
Two other Icahn proposals, to incorporate the company in North Dakota and to fix the size of the board at 13 seats, were rejected by shareholders, Biogen said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
